MedTrace Logo

Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men

NCT04237467 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2024-09-19

No results posted yet for this study

Summary

This study will examine markers of vascular endothelial function (vascular health) and metabolic profiles in older versus younger transgender men (people who were assigned female at birth but whose gender identity is male). Data will also be compared to those from age group-matched transgender women and cisgender women and men.

Conditions

  • Transgender
  • Gender Identity
  • Vascular Stiffness
  • Vascular Inflammation
  • Blood Pressure
  • Lipid Disorder
  • Appetitive Behavior

Interventions

OTHER

No intervention

There was no intervention.

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Sean Iwamoto, MD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-29
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04237467 on ClinicalTrials.gov